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Background: Changes to sexual wellbeing are acknowledged to be a long-term negative consequence of cancer
and cancer treatment. These changes can have a negative effect on psychological well-being, quality of life and
couple relationships. Whilst previous conclusions are based on univariate analysis, multivariate research can facilitate
examination of the complex interaction between sexual function and psycho-social variables such as psychological
wellbeing, quality of life, and relationship satisfaction and communication in the context of cancer, the aim of the
present study.
Method: Six hundred and fifty seven people with cancer (535 women, 122 men) and 148 partners (87 women,
61 men), across a range of sexual and non-sexual cancers, completed a survey consisting of standardized measures
of sexual functioning, depression and anxiety, quality of life, relationship satisfaction, dyadic sexual communication,
and self-silencing, as well as ratings of the importance of sex to life and relationships.
Results: Men and women participants, reported reductions in sexual functioning after cancer across cancer type, for
both people with cancer and partners. Multiple regression analysis examined psycho-social predictors of sexual
functioning. Physical quality of life was a predictor for men and women with cancer, and for male partners. Dyadic
sexual communication was a predictor for women with cancer, and for men and women partners. Mental quality of
life and depression were also predictors for women with cancer, and the lower self-sacrifice subscale of self-silencing
a predictor for men with cancer.
Conclusion: These results suggest that information and supportive interventions developed to alleviate sexual
difficulties and facilitate sexual renegotiation should be offered to men and women with both sexual and non-sexual
cancers, rather than primarily focused on individuals with sexual and reproductive cancers, as is the case currently. It
is also important to include partners in supportive interventions. Interventions aimed at improving sexual functioning
should include elements aimed at improving physical quality of life and sexual communication, with a focus on
psychological wellbeing also being important for women with cancer.
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Disruptions to sexuality after cancer
It is now widely recognized that cancer and its treatment
can have a significant effect on the quality of life of both
people with cancer and their family members, in par-
ticular their intimate partner [1]. Sexuality and intimacy
are important aspects of an individual’s quality of life
[2,3], and there is a growing body of evidence to show
that cancer can result in dramatic changes to sexuality,* Correspondence: j.perz@uws.edu.au
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unless otherwise stated.sexual functioning, relationships, and sense of self. These
changes can be experienced as the most important in the
person with cancer’s life [4,5], with the impact lasting for
many years after treatment [6,7], often resulting in sig-
nificant physical and emotional side-effects [8-10].
Sexual difficulties following cancer are primarily the
result of the effects of cancer treatments, rather than the
disease itself [11,12]. For women, the focus of research
has been on the impact of treatments for gynecological
or breast cancers, which can result in anatomical changes,
such as vaginal shortening or reduced vaginal elasticity
[13], pelvic nerve damage, clitoris removal, vaginal stenosis,. This is an Open Access article distributed under the terms of the Creative
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decreased bodily function [14], fatigue [15], dyspareunia
[16], vaginal dryness [17], infertility [18], and post-coital
vaginal bleeding [19]. Negative body image or feelings of
sexual un-attractiveness [6,20], concern about weight
gain or loss [21], loss of femininity [22], as well as alter-
ations to the sexual self [23], can exacerbate the impact
of these physical changes. In combination, this can result
in changes to women’s response [18], including changes
to: desire [18,24], orgasm [21,25], arousal [26], vaginal
lubrication [15,17], genital swelling [16] and genital sensi-
tivity [27], leading to decreased frequency of sex [28], and
lack of sexual pleasure or satisfaction [29,30].
Research examining men’s sexuality post-cancer has
primarily focused on prostate and testicular cancers
[31-33]. For example, men with prostate cancer have re-
ported that hormone therapy is like ‘chemical castration’
[34], resulting in erectile dysfunction [35,36], diminished
genital size, weight gain, urinary incontinence and bodily
feminization [37-39]. Other treatments reportedly result in
loss of sexual desire [40], reduced erotic dreams and sexual
fantasies [37], decreased orgasmic sensation, and bowel
and urinary incontinence [31]. Similarly, following surgery
for testicular cancer, men have reported reductions in sex-
ual functioning and enjoyment, fertility concerns, as well
as negative body image [41-44]. Rectal cancer has also been
associated with reductions in sexual functioning, for both
women and men [45,46].
There is some evidence that individuals with colorectal
[47-49], colon [50], head and neck [51,52], bladder [53],
lymphatic [54,55] and lung [56] cancers can also experi-
ence a reduction in sexual interest and sexual activity,
changes to body image and feelings of sexual competency,
as well as sexual dysfunction, and alterations to sexual
self-esteem [50,57,58]. Adult survivors of childhood can-
cer, across a range of cancer types and treatments, have
also been shown to report sexual difficulties and concerns
[59,60]. However, previous research on sexual changes
after cancer has primarily focused on cancers that directly
affect the sexual or reproductive organs, with each study
examining a single cancer type, precluding comparison
across sexual and non-sexual cancers. The present study
will address this imbalance in the research literature
through examining changes in sexual functioning and sex-
ual satisfaction, for both women and men, across a range
of cancer types, both sexual and non-sexual.
Pathways to sexual difficulty and distress after cancer
There is a growing body of research examining the
association between sexual changes experienced after
cancer and quality of life or psychological wellbeing
[10,36,47,48,58,61], suggesting that sexual difficulties are
associated with lower quality of life, and higher levels of
distress. For example, sexual changes have been found tobe associated with reduced quality of life or psychological
distress in men with prostate cancer [10,36,40,62-64],
rare cancers [58], lymphoma [65,66], and colorectal can-
cer [47]. For women, sexual difficulties have been associ-
ated with reduced quality of life or distress in the context
of breast cancer [17,67,68], cervical cancer [20,61,69-71],
and colorectal cancer [47,48]. Other studies have mea-
sured sexual functioning and quality of life as inde-
pendent outcome variables, but have not examined the
relationship between the two [72-75].
A number of factors have been examined as possible
predictors of sexual difficulties and psychological distress
after cancer, primarily focusing on demographic charac-
teristics such as age [45,47,56,65,76], gender [45,47,48,60],
ethnicity [64,77], marital status [68], or education [45,78],
as well as the influence of treatment type [45,47,69,73,79].
Older age [45,47,65], and radiation treatment [10,61,69,76]
have been consistently associated with lower levels of sex-
ual functioning, with a number of studies also reporting
gender differences in demographic predictors of function-
ing [45,47,79]. However, characteristics of the individual
with cancer are not the only predictors of sexual function-
ing post-diagnosis and treatment. Relationship factors are
recognized as having a significant influence on sexual diffi-
culties experienced outside of the cancer context [80], yet
the association between relationship factors and sexual ad-
justment after cancer has been neglected [47]. There is
some evidence that quality of the couple relationship is as-
sociated with sexual satisfaction and higher levels of sexual
functioning [81], and that couples’ quality of life and mari-
tal satisfaction are linked [36], in the context of cancer.
Successful renegotiation of sexual practices after cancer
has also been reported to be associated with couple com-
munication, in qualitative research conducted with cancer
carers [82,83]. Nevertheless, these findings are limited, and
are primarily based on univariate analysis. The present
study will address this limitation in previous research,
through conducting multifactorial research to examine the
complex interaction between sexual function and psycho-
logical wellbeing, quality of life, and relationship satisfac-
tion and communication, in the context of cancer [71,84].
Relationship communication and context
There is a dearth of previous research examining the in-
fluence of couple communication on sexual functioning
for people with cancer. There is, however, evidence that
the adoption of an open and responsive pattern of couple
communication after cancer is associated with lower levels
of distress and higher levels of marital satisfaction [85,86],
as well as effective emotion and problem focused coping
[87], associated with relationship closeness [88,89]. Con-
versely, many partners are over-protective towards the
person with cancer, engaging in “protective buffering” in
an attempt to prevent distress [90,91], or “disengaged
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cer or its effects. This buffering or avoidance is analogous
to the pattern of self-silencing initially identified by Dana
Jack [92] as an explanation for women’s greater suscepti-
bility to depression. Self-silencing is characterized as the
propensity to engage in compulsive caretaking, pleasing
the other, and inhibition of self-expression in relationships,
in an attempt to achieve intimacy and meet relational
needs [93]. Self-silencing is not a pattern of behaviour
unique to women. In a number of studies men have been
found to report levels of self-silencing equal to those of
women [94,95], or higher than women [96-98]. Differences
have also been reported between women and men in pat-
terns of self-silencing [99], and in the relationship between
self-silencing and psychological well-being. For example,
there is evidence that whilst men report significantly
higher self-silencing than women, they also report lower
depression [96,100], a finding reported in a recent study
of cancer carers [98], whereas self-silencing is posi-
tively correlated with depression in women [100]. The
present study will examine the association between self-
silencing and sexual functioning, as part of a broader
multifactorial analysis, in women and men with cancer,
as well as partners of a person with cancer, the first study
to do so.
Cancer affects not only the person who receives a can-
cer diagnosis, but also their significant other, leading to
the description of cancer as a ‘we-disease’ [88]. Whilst
the experiences of partners are often neglected in re-
search on sexuality and intimacy post-cancer [101,102],
there is growing acknowledgement of their unmet needs
in this area [82,103-105]. Reported disruptions for part-
ners include decreases in sexual drive, fear of initiating
sex with their partner, difficulty regaining a level of ‘nor-
mality’ within the sexual relationship, sexual communi-
cation difficulties, and feeling unwanted and unattractive
because of the cessation of sex [34,83,102,106-109]. The
present study will, therefore, examine the sexual experi-
ences of partners in comparison with people with cancer,
across sexual and non-sexual cancer types, to address
this gap in the research literature.
Study aims and research questions
The aim of this study is to examine the nature of
changes in sexual functioning post-cancer and to evaluate
the interaction between sexual function and psychological
distress, quality of life, and relationship satisfaction and
communication. The following research questions are
examined. For both men and women with cancer, and
their partners, across sexual and non-sexual cancers: How
important is sexuality post-cancer? What are the changes
in sexual functioning reported before and post-cancer?
What psycho-social factors are associated with reductions
in sexual functioning post-cancer? What is the relativecontribution of psycho-social factors in predicting reduc-
tions in sexual functioning?
Method
Participants
Six hundred and fifty seven people with cancer (535
women, 122 men) and 148 partners (87 women, 61 men)
took part in the study, part of a larger mixed methods
study examining the construction and experience of
changes to sexuality after cancer. We recruited Australian
participants nationally through cancer support groups,
media stories in local press, advertisements in cancer
and carer specific newsletters, hospital clinics, and local
Cancer Council websites and telephone helplines. After
reading detailed information describing the research
team, the study, consent and complaint procedures, par-
ticipants completed an online or postal questionnaire
examining their experiences of sexuality and intimacy
post-cancer. As detailed in the study information sheet,
consent to participate was implied through the comple-
tion and return of the questionnaire. At the end of the
survey, participants indicated whether they would like to
be considered to take part in a one hour interview, to dis-
cuss changes to sexuality in more depth (additional written
consent was obtained for the interviews, with qualitative
data reported elsewhere) [110-114]. Two individuals, a
person with cancer and a partner, nominated by a cancer
consumer organization acted as consultants on the project,
commenting on the design, method and interpretation of
results. We received ethical approval from the University
of Western Sydney Human Research Ethics Committee,
and from three Health Authorities (Sydney West Area
Health Service, South East Sydney Illawarra Health Service,
and St Vincent’s Hospital, Sydney), from which participants
were drawn.
Measures
Changes in Sexual Functioning Questionnaire (CSFQ-14)
A 14 item validated instrument that provides a global
measure of sexual functioning, using a 5 point Likert
scale [115]. It has five subscales identifying different
aspects of sexual functioning: desire/frequency; desire/
interest; arousal excitement; orgasm/completion; and
pleasure, with higher scores indicating higher levels of
reported functioning. In reliability testing, the Cronbach
alpha coefficients for the total CSFQ-14 score of .90 for
the female version and .89 for the male version have been
found [115].
Hospital Anxiety and Depression Scale (HADS)
A 14 item validated measure developed to measure anx-
iety and depression in non-psychiatric populations [116].
Each subscale HADSA (anxiety) and HADSD (depression)
has a maximum possible score of 21, with a score of
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cut-off for clinical diagnosis. A score of 8-10 is catego-
rized borderline, and a score of 11 and above categorized
as abnormal in relation to caseness [117]. In a review of
the psychometric literature on HADS, Cronbach alpha co-
efficients for HADS-A varied from .68 to .93 (mean .83)
and for HADS-D from .67 to .90 (mean .82) [117].
Medical outcomes study health survey short form (SF-12)
Used to measure health-related quality of life. This
measure has been used to evaluate functional states in
depressed, chronically ill and healthy populations. The
SF-12 is comprised of 12 items, measuring two compo-
nents: mental health and physical health [118]. Partici-
pants rate the degree to which their quality of life is
compromised due to their health, on a series of Likert
scales. High scores indicate a better quality of life. The
SF-12 has good internal consistency and test-retest reli-
ability. Sufficient evidence for the internal consistency of
the revised SF-12 as been found (Cronbach alpha coeffi-
cients of 0.72 to 0.89) [119].
Brief Dyadic Adjustment Scale (DAS)
A 7 item validated instrument which examines relation-
ship satisfaction and cohesion, using a 6-point Likert
scale [120]. Higher scores are indicative of higher levels
of relationship satisfaction. DAS has shown good in-
ternal consistency with Cronbach alpha coefficient of .85
reported [121].
Dyadic sexual communication scale
A 13 item scale assessing perceptions of the communi-
cation process encompassing sexual relationships, using
a 6-point Likert scale, with higher scores associated with
better quality of perceived communication [122]. The in-
ternal consistency of the DSC has been tested among a
cohabitating sample, with a Cronbach alpha coefficient
of .83 found [122].
The Silencing the Self Scale (STSS)
A standardized questionnaire consisting of 31 items
measuring the extent to which individuals endorse self-
silencing thoughts and actions in intimate relationships,
using a 5 point Likert scale [92]. In addition to a Global
score, the four subscales are: Care as Self-Sacrifice (e.g.
Caring means putting the other person’s needs in front
of my own), Silencing the Self (e.g. I don’t speak my
feelings in an intimate relationship when I know they
will cause disagreement), Externalized Self Perception
(e.g. I tend to judge myself by how I think other people
see me) and The Divided Self (e.g. Often I look happy
enough on the outside, but inwardly I feel angry and re-
bellious). High scores indicate greater self-silencing. The
internal consistency of total STSS and subscales has beenfound to range from Cronbach alpha coefficients of .65
to .94 [95].
Ratings of sexual importance and activity
Were obtained by participants responding to separate
items on the importance of sex as a part of their relation-
ship and as a part of their life on a three point scale: not
important, somewhat important, very important. Partici-
pants also reported with a yes/no response whether their
sexual activities had changed since the onset of cancer.
Statistical analysis
Univariate analyses were conducted to compare women
and men on each of the socio-demographic variables of
interest separately for people with cancer (PWC) and
partners of people with cancer (PPWC). For continuous
variables, one-way ANOVA were conducted with gender
as the grouping variable, and the chi square test for inde-
pendence used for frequency data. Participants reported
a range of cancer types, which were categorized into sex-
ual (breast, gynecological, prostate, genito-urinary) and
non-sexual (hematological/blood, digestive/gastrointestinal,
neurologic, skin and other) for the purpose of analysis.
The chi square test for independence was used to test for
group differences between sexual and non-sexual cancer
types, and women and men, on measures of sexual im-
portance and activity, for both PWC and PPWC. To as-
sess change in sexual functioning after cancer, paired
sample t-tests were conducted separately for women and
men for PWC and PPWC. Preliminary analyses to mul-
tiple regression analyses included independent sample
t-tests to assess gender differences in mean scores for all
potential predictor variables, and Pearson’s correlations
to assess associations between the sexual functioning
measures and the criterion total sexual functioning and
potential predictor variables for women and men across
PWC and PPWC. Finally, to evaluate the relationship be-
tween the set of potential predictor variables and the cri-
terion, and identify those variables responsible for the
variation in the criterion, standard multiple linear re-
gression analyses were conducted for women and men
in the PWC and PPWC samples. Exact alpha levels are
reported for all statistical tests, with table notations in-
dicating significance at the .05, .01 or greater than .001
levels where relevant. Ninety-five precent confidence in-




Tables 1 and 2 present the sample demographics by
gender for the PWC and PPWC samples. Years since
first diagnosis of cancer, ethnicity profile, relationship
status, and current involvement in a sexual relationship
Table 1 Sample characteristics by gender for People with Cancer (PWC)
Women Men Test for group difference Significance Effect size
Variable n M (SD) n M (SD) F p η2
Patient age 535 50.7 (10.9) 122 61.1 (14.3) 79.01 <0.001 0.108
Years since first diagnosis 533 4.9 (5.3) 122 5.3 (5.4) 0.53 0.468 0.001
Length of current relationship 515 19.8 (13.7) 118 25.7 (16.8) 16.55 <0.001 0.026
n % n % χ2 p φ
Ethnicity: 0.51 0.774 0.028
Aust/White European 508 95.7 114 94.2
Asian 14 2.6 4 3.3
Other 9 1.7 3 2.5
Cancer type: 519.19 <0.001 0.364
Breast 425 80 - -
Gynecologic 45 8.5 - -
Prostate - - 87 72.5
Genitourinary (other) 4 0.8 7 5.8
Hematological/Blood 23 4.3 14 11.7
Digestive/Gastrointestinal 11 2.1 4 3.3
Neurologic 6 1.1 4 3.3
Skin 8 1.5 2 1.7
Othera 9 1.7 2 1.7
Cancer classification: 10.52 .001 0.127
Sexual cancer type 474 89.3 94 78.3
Non-sexual cancer type 57 10.7 26 21.7
Stage of disease: 27.19 <0.001 0.188
No longer detectable/In remission 430 80.8 71 58.7
Receiving treatment 16 3.0 7 5.8
Otherb 86 16.2 43 35.5
Relationship status: 3.12 0.374 0.032
Partnered – Living together 414 77.4 96 78.7
Partnered – Not living together 34 6.4 10 8.2
Not in a relationship 76 14.2 16 13.1
Other/Not specified 11 2.1 - -
Sexual identity: 405.16 <0.001 0.858
Heterosexual 434 96.7 92 91.1
Non heterosexual 15 3.3 9 8.9
Current sexual relationship: 0.99 0.319 0.039
Yes 404 76.2 87 71.9
No 126 23.8 34 18.6
Note a“Other” includes: Respiratory/Thoracic, Head & Neck, various, each less than 1%; b “Other” includes: a new different cancer; active monitoring; outcome
not specified.
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men were significantly older, 61.1 versus 50.7 years old,
had been in their current relationship longer, 25.7 years
versus 19.8 years, were more likely to identify as non-
heterosexual, 8.9% versus 3.3%, were less likely to reporta sexual cancer, 78% versus 89%, and were less likely to
be in remission, 59% versus 81% (Table 1). For the PPWC
sample, partner age, length of current relationship, rela-
tionship status, sexual identity, involvement in a current
sexual relationship, ethnicity profile, years since partner’s
Table 2 Sample characteristics by gender for partners of People with Cancer (PPWC)
Women Men Test for group difference Significance Effect size
Variable n M (SD) n M (SD) F p η2
Partner age 87 54.1 (13.5) 61 54.8 (11.1) 0.11 0.738 0.001
Years since partner’s first diagnosis 87 2.9 (2.0) 61 2.9 (2.0) 0.01 0.932 0.000
Length of current relationship 87 25.0 (16.2) 61 23.8 (13.2) 0.24 0.629 0.002
n % n % χ2 p φ
Ethnicity: 0.85 0.653 0.056
Aust/White European 82 97.6 57 95.0
Asian 1 1.2 2 3.3
Other 1 1.2 1 1.7
Cancer type: 60.10 <0.001 0.297
Breast 4 4.6 29 48.3
Gynecologic 4 4.6 9 15
Prostate 35 40.2 2 3.3
Genitourinary (other) 6 6.9 - -
Hematological/Blood 15 17.2 10 16.7
Digestive/Gastrointestinal 11 12.6 6 10.0
Neurologic 2 2.3 1 1.7
Skin 2 2.3 1 1.7
Othera 8 9.2 2 3.3
Cancer classification: 1.60 0.207 0.104
Sexual cancer type 49 56.3 40 66.7
Non-sexual cancer type 38 43.7 20 33.3
Stage of disease: 3.11 0.375 0.095
No longer detectable/In remission 52 59.8 41 67.2
Receiving treatment 2 2.3 3 4.9
Otherb 33 37.9 17 27.9
Relationship status: 0.12 0.896 0.011
Partnered – Living together 79 90.8 55 90.2
Partnered – Not living together 8 9.2 6 9.8
Sexual orientation: 36.16 0.525 0.086
Heterosexual 79 90.8 55 90.2
Non heterosexual 8 9.2 6 9.8
Current sexual relationship: 0.12 0.729 0.039
Yes 70 81.4 51 83.6
No 16 18.6 10 16.4
Note a “Other” includes: Respiratory/Thoracic, Head & Neck, various, each less than 1.5%; b “Other” includes: a new different cancer; active monitoring; outcome
not specified.
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fication, and stage of disease, did not differ by gender
(Table 2).
Measures of sexual importance and sexual activity for
PWC and PPWC according to gender and sexual or
non-sexual cancer classification are presented in Tables 3
and 4. PWC men were more likely to rate the import-
ance of sex to their relationships and as a part of lifeas very or somewhat important (97.9% and 96.6%, re-
spectively) than women (86.2% and 78.2%, respectively).
There was no significant difference in the reporting of
changes in sexual activities since the onset of caner for
men (84.6%) and women (76.8%), with the majority of both
groups reporting a change. For PPWC, men (91.8%) were
more likely than women (84.7%) to rate sex as very to
somewhat important as a part of life.
Table 3 Sexual importance and activity by gender and cancer classification for People with Cancer (PWC)




Test for group difference
Item/Variable n % n % χ2 p φ n % N % χ2 p φ
Sex important part of the relationship: 13.17 0.001 0.158 2.715 0.257 0.072
Very important 148 34.3 45 48.4 162 35.7 30 46.2
Somewhat important 224 51.9 46 49.5 238 52.4 28 43.1
Not important 60 13.9 2 2.2 54 11.9 7 10.8
Sex important part of life: 39.59 <0.001 0.248 9.965 0.007 0.125
Very important 125 23.7 57 48.7 146 26.2 35 42.7
Somewhat important 288 54.5 56 47.9 304 54.6 37 45.1
Not important 115 21.8 4 3.4 107 19.2 10 12.2
Change in sexual activities since
onset of cancer:
3.417 0.065 0.074 2.951 0.086 0.069
Yes 394 76.8 99 84.6 432 79.1 55 70.5
No 119 23.2 18 15.4 114 20.9 23 29.5
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ship, and the report of changes to sexual activity post-
cancer did not differ between the sexual and non-sexual
cancer classifications, with the majority in both groups
nominating importance and a change in activities. Non-
sexual cancer PWC were more likely to rate the im-
portance of sex as a part of life as very or somewhat
important than sexual cancer PWC (87.8% and 80.8%
respectively). For the PPWC sample, cancer classifica-
tion groupings did not differ in reports on sexual im-
portance and activity levels, with the majority in both
groups indicating the importance of sex to the relation-
ship and life, and a change in activities, post-cancer. As
the impact of cancer upon sexual importance and activ-
ity is sufficiently similar across sexual/non-sexual cancerTable 4 Sexual importance and activity by gender and cancer
Women Men Test for gro
Item/Variable n % n % χ2 p
Sex important part of the relationship: 5.24 0.0
Very important 24 31.6 27 50.9
Somewhat important 41 53.9 22 41.5
Not important 11 14.5 4 7.5
Sex important part of life: 9.43 0.0
Very important 20 23.5 29 47.5
Somewhat important 52 61.2 27 44.3
Not important 13 15.3 5 8.2
Change in sexual activities since
onset of cancer:
1.37 0.1
Yes 62 75.6 40 66.7
No 20 24.4 20 33.3
Note. The CSFQ Sexual Pleasure Subscale is only available for ‘after cancer’.classification groups for the PWC and PPWC samples,
subsequent analyses did not test for differences between
these groups.
Sexual functioning according to gender
Paired sample t-tests were conducted for both women
and men PWC and PPWC on CSFQ subscales and total
scores (Tables 5 and 6) comparing changes in sexual
functioning before cancer to after cancer. Cross gender
statistical comparison on the CSFQ is not possible, as
the scales are specific to men and women. For all CSFQ
scores across women and men PWC, sexual functioning
scores were significantly lower after cancer than before
cancer. Cohen’s effect size values ranged from d = 1.228





Test for group difference
φ n % n % χ2 p φ
73 0.202 0.80 0.672 0.079
33 42.9 18 35.3
35 45.5 27 43.5
9 11.7 6 11.8
09 0.254 2.11 0.348 0.121
31 35.6 18 31.0
43 49.4 35 60.3
13 14.9 5 8.7
63 0.098 0.68 0.411 0.035
64 73.6 38 70.4
23 26.4 16 29.6
Table 5 CSFQ subscales by gender for People with Cancer (PWC)
Women Test for group
difference
Sign. Effect size Men Test for group
difference
Sign. Effect size
Subscale n M(SD) t p d n M(SD) t p d
Sexual desire/frequency 21.28 <0.001 1.403 8.73 <0.001 1.388
Before cancer 520 6.85 (1.64) 117 7.40 (1.33)
After cancer 520 4.92 (1.86) 117 5.86 (1.97)
Sexual desire/interest 16.63 <0.001 1.228 6.75 <0.001 1.285
Before cancer 516 8.82 (2.51) 115 10.74 (2.12)
After cancer 516 6.77 (2.62) 115 9.17 (2.44)
Sexual arousal 21.01 <0.001 1.459 16.96 <0.001 1.807
Before cancer 509 11.17 (3.01) 114 13.69 (1.42)
After cancer 509 7.27 (3.12) 114 9.26 (2.52)
Sexual orgasm 18.13 <0.001 1.342 16.32 <0.001 1.924
Before cancer 504 12.04 (2.95) 109 12.29 (1.90)
After cancer 504 8.72 (3.97) 109 6.88 (3.32)
Total sexual functioning 13.67 <0.001 1.359 10.49 <0.001 1.547
Before cancer 446 42.22 (7.37) 104 46.55 (5.36)
After cancer 446 34.73(10.45) 104 36.48 (9.30)
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orgasm scores, suggesting a high practical significance in
the level of pre to post cancer change.
For the PPWC sample, all CSFQ sexual functioning
scores for women were significantly lower after cancer
as compared to before cancer scores. For men, all post-
cancer sexual functioning scores were lower than beforeTable 6 CSFQ subscales by gender for partners of People with
Women Test for group
difference
Sign.
Subscale n M(SD) t p
Sexual desire/frequency 9.75 <0.001
Before cancer 80 6.96 (1.44)
After cancer 80 5.24 (1.62)
Sexual desire/interest 3.93 <0.001
Before cancer 77 8.26 (2.58)
After cancer 77 7.38 (2.49)
Sexual arousal 4.62 <0.001
Before cancer 79 11.51 (5.18)
After cancer 79 9.03 (3.05)
Sexual orgasm 3.73 <0.001
Before cancer 77 12.45 (5.45)
After cancer 77 9.60 (5.21)
Total sexual functioning 3.39 0.001
Before cancer 70 41.01 (7.28)
After cancer 70 37.13(9.61)
Note. The CSFQ Sexual Pleasure Subscale is only available for ‘after cancer’.cancer scores with the exceptions of sexual desire/
interest and total sexual functioning scores, where differ-
ences did not reach statistical significance. In all instances
where statistical significance was reached, Cohen’s effect
size values indicated a moderate to high practical signifi-
cance in the observed change from pre to post cancer
levels.Cancer (PPWC)
Effect size Men Test for group
difference
Sign. Effect size
d n M(SD) t p d
1.125 6.38 <0.001 1.327
58 7.28 (1.47)
58 5.98 (1.57)
1.031 1.45 0.152 0.711
55 11.13(5.94)
55 10.04 (2.46)
0.939 3.85 <0.001 1.192
56 8.39 (1.63)
56 7.82 (1.82)
0.946 2.54 0.014 1.029
52 17.54 (6.10)
52 15.48 (2.69)
1.244 1.057 .296 1.046
50 46.74(13.21)
50 44.78 (7.14)
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relationship measures according to gender
Univariate analyses were used to compare women and
men on health related QoL, psychological distress and
relationship variables of interest. With assumptions
of normality and homogeneity of variance met in all in-
stances, independent t-tests were conducted with gender
as the grouping variable. Table 7 presents the descriptive
data and comparisons between gender for all variables
for the PWC sample. For mental health related quality of
life, anxiety, dyadic adjustment and sexual communi-
cation, and three STSS subscales, results indicated a
statistically significant difference for women and men,
with women experiencing higher levels of anxiety and
‘externalized self perception’ self-silencing, and lower
levels of mental health related QOL, relationship sat-
isfaction and sexual communication. For the STSS sub-
scales ‘silencing the self ’ and ‘care as self-sacrifice’, men
reported significantly higher self-silencing scores than
women. For the PPWC sample, results indicated that
women reported a higher ‘externalized self-perception’
STSS subscale score than men, with the differences be-
tween women and men on all other variables not being
statistically significant (Table 8).
The correlations between all potential predictor vari-
ables and sexual functioning measures according to gen-
der are presented in Table 9 for the PWC sample. For
women, all health related QoL, psychological distress
and relationship measures were significantly associated
with total sexual functioning scores and the majority of
sexual functioning subscale scores on the CSFQ. Signifi-
cant positive correlations were observed for the SF12
subscales, DAS and DSCS and sexual functioning scores,
whereas HADS and STSS subscales were significantly
inversely correlated with sexual functioning scores. ForTable 7 Means (standard deviations) and comparisons betwe
with Cancer (PWC)
Women Me
Variable M (SD) M (S
SF12-Physical component summary 46.33 (10.88) 46.88 (
SF12-Mental component summary 45.25 (11.42) 48.37 (
HADS-Anxiety 9.75 (2.41) 8.68 (
HADS-Depression 8.12 (2.15) 7.78 (
Dyadic Adjustment Scale (DAS) 27.73 (4.09) 28.57
Dyadic Sexual Communication (DSCS) 46.06 (11.63) 48.47 (
Silencing the Self Scale (STSS)
Externalized self perception 17.34 (5.48) 15.69
Silencing the self 23.55 (7.74) 26.78
Care as self sacrifice 24.78 (5.93) 31.49
Divided self 16.38 (6.45) 16.58men in the PWC sample, SF12 health related QoL and
DAS measures had significant positive correlations with
sexual functioning total scores, as compared to the
‘silencing the self ’ and ‘care as self-sacrifice’ STSS sub-
scales which were negatively associated with total sexual
functioning.
For the PPWC sample, fewer potential predictor var-
iables were significantly correlated with sexual func-
tioning scores (Table 10). For women, the relationship
between relationship satisfaction and sexual communi-
cation measures - DAS and DSCS - were significantly
positively correlated with sexual functioning total and the
majority of the subscales, whilst the ‘care as self-sacrifice’
subscale of the STSS was negatively associated with
sexual functioning. Significant positive correlations were
observed between the physical health summary score of
the SF12 and relationship communication (DSCS) and
sexual functioning total and subscales scores, with the
STSS ‘silencing the self ’ subscale inversely related to
sexual functioning for men PPWC.
Prediction of sexual functioning
Standard multiple linear regression analyses were
conducted to evaluate how well health related QoL,
psychological distress, relationship satisfaction, sexual
communication and self-silencing measures predicted
women and men’s total sexual functioning scores for
the PWC and PPWC samples. Evaluations of assump-
tions were satisfactory with no outliners with a standard-
ized residual > 3, and no cases found with a Mahalanobis
distance score of p < .001 for all analyses performed.
To maximize the cases-to-IVs-ratio, potential predic-
tors with non-significant zero-order correlations (as
identified in Tables 9 and 10) were excluded in the regres-
sion analyses [123]. In all analyses, no multicollinearityen gender for all potential predictor variables for People
n
D) t (655) p 95% CI η2
10.23) -0.51 .609 [-2.67, 1.57] .000
10.42) -2.77 .006 [-5.34, -0.91] .012
3.12) 4.19 <.001 [0.57, 1.58] .026
3.05) 1.65 .099 [-0.73, 0.85] .004
(3.83) -1.99 .047 [-1.65, -0.01] .006
11.04) -2.03 .043 [-4.74, -0.73] .007
(5.21) 3.01 .003 [0.57, 2.73] 0.14
(6.77) -4.16 <.001 [-4.76, 1.71] .027
(5.58) -11.16 <.001 [-7.89, -5.53] .165
(6.45) -0.30 .767 [-1.51, 1.11] .000
Table 8 Means (standard deviations) and comparisons between gender for all potential predictor variables for Partners
of People with Cancer (PPWC)
Women Men
Variable M (SD) M (SD) t (655) p 95% CI η2
SF12-Physical component summary 51.05 (9.12) 51.28 (8.24) -0.16 .873 [-3.13, 2.66] .000
SF12-Mental component summary 45.55 (12.01) 48.32 (12.01) -1.38 .169 [-6.74, -1.19] .013
HADS-Anxiety 11.10 (2.49) 11.59 (2.93) -1.10 .275 [-1.39, 0.40] .008
HADS-Depression 8.80 (2.02) 8.78 (2.35) 0.06 .956 [-0.73, 0.74] .000
Dyadic Adjustment Scale (DAS) 28.33 (3.91) 29.29 (3.46) -1.52 .130 [-2.21, 0.29] .016
Dyadic Sexual Communication (DSCS) 46.43 (13.04) 48.65 (10.20) -1.10 .275 [-6.22, 1.78] .008
Silencing the Self Scale (STSS)
Externalized self perception 17.76 (8.90) 14.97 (5.78) 2.13 .035 [0.20, 5.39] .031
Silencing the self 26.05 (8.13) 25.93 (9.54) 0.83 .934 [-2.79, 3.03] .000
Care as self sacrifice 28.71 (8.39) 30.15 (6.10) -1.12 .267 [-3.99, 1.11] .009
Divided self 15.70 (6.49) 15.31 (6.61) 0.35 .724 [-1.80, 2.59] .001















SF12-Physical component summary .14** .15** .13** .14** .17** .15**
SF12-Mental component summary .20** .07 .21** .21** .31** .22**
HADS-Anxiety -.11* -.02 -.12** -.10* -.18** -.16**
HADS-Depression -.10* -.05 -.14** -.13** -.18** -.20**
Dyadic Adjustment Scale (DAS) .28** .04 .21** .13** .37** .22**
Dyadic Sexual Communication (DSCS) .35** .18** .31** .31** .46** .34**
Silencing the Self Scale (STSS)
Externalized self perception -.20** -.23** -.26** -.21** -.27** -.20**
Silencing the self -.24** -.17** -.15** -.26** -.25** -.28**
Care as self sacrifice -.10* -.18** -.21** -.21** -.08 -.18**
Divided self -.34** -15** -.25** -.28** -.40** -3.32**
Men
SF12-Physical component summary .42** .16 .16 .23* .36** .33**
SF12-Mental component summary .16* .11 .10 .10 .16* .17*
HADS-Anxiety .04 .02 -23** -20* -.04 -.11
HADS-Depression .02 .03 -.19* -.20* -.06 -.09
Dyadic Adjustment Scale (DAS) .21* .09 .07 .12 .30** .19*
Dyadic Sexual Communication (DSCS) .17* -.10 .06 .13 .43** .11
Silencing the Self Scale (STSS)
Externalized self perception -.08 -.19* -.03 -.06 -.07 -.15
Silencing the self -.25** -.01 -.21* -.24** -.25** -.24**
Care as self sacrifice -.28** -.04 -.27** -.25** -.13 -.27**
Divided self -.12 -.03 -.09 -.10 -.29** -.12
Note. *p < .05; **p < .01, one-tailed.
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SF12-Physical component summary .22* .24* .28** -.14 .15 .12
SF12-Mental component summary .13 .01 .13 .07 .32** .13
HADS-Anxiety .14 .17 .15 .01 .20* .13
HADS-Depression -.07 -.03 -.08 -.18 -.15 -.18
Dyadic Adjustment Scale (DAS) .39** .17 .24* .11 .51** .26**
Dyadic Sexual Communication (DSCS) .49** .30** .37** .04 .53** .33**
Silencing the Self Scale (STSS)
Externalized self perception -.19* -.14 .08 -.11 -.23* -.13
Silencing the self -.17 -.10 -.18 -.09 -.22* -.16
Care as self sacrifice .02 .07 -.15 -.26** .00 -.19*
Divided self -.23* -.08 -.14 -.01 -.42** -.17
Men
SF12-Physical component summary .06 .26* .27* .37** .12 .33**
SF12-Mental component summary .40** -.28* -.14 -.04 .45** .06
HADS-Anxiety .29* -.13 -.15 -.03 .33** -.03
HADS-Depression -.04 .17 .05 -.02 -.09 .12
Dyadic Adjustment Scale (DAS) .11 -.10 .01 .11 .31** .11
Dyadic Sexual Communication (DSCS) .49** -.08 .18 .18 .64** .34**
Silencing the Self Scale (STSS)
Externalized self perception -.22* .40** .12 -.04 -.26* .07
Silencing the self -.25* -.09 -.09 -.26* -.25* -.23*
Care as self sacrifice -.14 -.21 .00 -.11 -.06 -.08
Divided self -.31** .30* -.06 -.20 -.48** -.13
Note. *p < .05; **p < .01, one-tailed.
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ficients < .90. Tables 11 and 12 display the unstandardized
regression coefficients (B) and intercept, the standardized
regression coefficients (β), the semipartial correlations
(sr2), R2, adjusted R2, R, and the confidence limits for sig-
nificant semipartial coefficients for the conducted regres-
sion analyses. Semipartial correlation coefficients are a
useful measure for interpretation as they indicate how
much each variable uniquely contributes to R2 (total
amount of variance in the criterion accounted for by
the predictor variables) over and above that which can
be accounted for by the other predictor variables.
For the women PWC sample, the full regression model
significantly explained 22% the variance in total sexual
functioning scores, F(10, 377) = 9.85, p < .001, adj R2 = .22,
95% CI [-2.38, 26.82]. The relative strength of the individ-
ual predictors is presented in Table 11. Squared semipar-
tial correlations indicate that four variables contributed
uniquely to the prediction of sexual functioning scores,
explaining 9% of the variance. The size and direction ofthe relationships indicated by the observed standardized
regression coefficients suggests higher levels of sexual
functioning for women PWC is associated with higher
physical and mental health related quality of life and
dyadic sexual communication, and lower depression. For
the men PWC sample, the linear combination of five pre-
dictors significantly explained 12% of the variance in total
sexual functioning scores, F(5, 95) = 3.68, p = .004, adj
R2 = .12, 95% CI [8.95, 51.01]. Only two predictors dis-
played significant semipartial correlations, suggesting
that higher levels of sexual functioning in men PWC is
uniquely associated with higher physical health related
quality of life and lower levels of the ‘care as self-sacrifice’
subscale of the STSS.
Table 12 displays the results of the standard multiple
regressions for the women and men PPWC samples.
The full three variable regression model significantly ex-
plained 9% of the variance in total sexual functioning
scores, F(3,73) = 3.50, p = .02, adj R2 = .09, 95% CI 10.54,
45.46], in the women PPWC sample. Only the semipartial
Table 11 Multiple regression analysis predicting csfq
total sexual functioning scores from predictor variables
by gender for People with Cancer (PWC)
Women
Variable B β sr2 (unique)
SF12-Physical component summary .16*** .17 .03
SF12-Mental component summary .11* .12 .01
HADS-Anxiety .26 .06
HADS-Depression -.59* -.12 .01
Dyadic Adjustment Scale (DAS) .23 .09
Dyadic Sexual Communication (DSCS) .23*** .25 .04
Silencing the Self Scale (STSS)
Externalized self perception .01 .00
Silencing the self -.13 -.09
Care as self sacrifice -.11 -.06
Divided self .01 .01
(Intercept) 12.20
R2 .21a
Total Adj. R2 .22
R .46***
95% Confidence limits from 0.14 to 0.28
Men
SF12-Physical component summary .24* .24 .05
SF12-Mental component summary .09 .09
Dyadic Adjustment Scale (DAS) .20 .08
Silencing the Self Scale (STSS)
Silencing the self -.04 -.03
Care as self sacrifice -.42* -.24 .05
(Intercept) 29.98
R2 .10b
Total Adj. R2 .12
R .41**
95% Confidence limits from 0.04 to 0.30
a. Unique variability = .09; shared variability = 12%.
b. Unique variability = .10; shared variability = 7%.
*p < .05, **p < .01, ***p < .001.
Table 12 Multiple regression analysis predicting CSFQ
total sexual functioning scores from predictor variables
by gender for Partners of People with Cancer (PPWC)
Women
Variable B β sr2 (unique)
Dyadic Adjustment Scale (DAS) .20 .08
Dyadic Sexual Communication (DSCS) .20* .27 .05
Silencing the Self Scale (STSS)
Care as self sacrifice -.15 -.14
(Intercept) 28.00
R2 .13a
Total Adj. R2 .09
R .36*
95% Confidence limits from 0.14 to 0.28
Men
SF12-Physical component summary .30* .35 .11
Dyadic Sexual Communication (DSCS) .25* .36 .11
Silencing the Self Scale (STSS)
Silencing the self .03 .04
(Intercept) 16.33
R2 .23b
Total Adj. R2 .18
R .48**
95% Confidence limits from 0.04 to 0.42
a. Unique variability = .05; shared variability = 8%.
b. Unique variability = .22; shared variability = 0.9%.
*p < .05, **p < .01.
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total sexual functioning scores was significant, uniquely
explaining 5% of the variance. The size and direction
of the standardized regression coefficient suggests that
higher levels of sexual functioning for women PPWC is
associated with higher levels of dyadic sexual communi-
cation. For the men PPWC sample, the full regression
model significantly explained 18% of the variance in
total sexual functioning scores, F(3, 50) = 4.66, p = .006,
adj R2 = .18, 95% CI [-4.28, 36.94]. Two predictors dis-
played significant semipartial correlations, suggesting
that higher levels of sexual functioning in men PPWCis uniquely associated with higher physical health re-
lated quality of life and dyadic sexual communication.
Discussion
This study documented changes in sexual functioning
post-cancer for both individuals with cancer, and their
partners, across sexual and non-sexual cancers, and
demonstrated an association between sexual function and
psychological distress, quality of life, sexual communica-
tion, and aspects of self-silencing, using a multivariate
analyses. Our findings extend previous research examining
psycho-social factors associated with sexual changes expe-
rienced after cancer, reinforcing, in particular, the import-
ance of physical wellbeing and sexual communication in
the context of relationships.
In contrast to previous research that focused on can-
cers that directly affect the sexual and reproductive or-
gans, in the present study we examined a range of cancer
types, finding that sexuality was rated as important, with
changes to sexual activities and functioning reported,
across sexual and non-sexual cancers. Indeed, individuals
with a non-sexual cancer were more likely than those
with a sexual cancer to rate sex as an important aspect of
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sionals working in cancer care that sexuality is primarily
a matter of concern for individuals experiencing cancers
that directly affect the sexual and reproductive organs
[124]. It also suggests that information and supportive in-
terventions developed to alleviate sexual difficulties and
facilitate sexual renegotiation should be offered to indi-
viduals with both sexual and non-sexual cancers, rather
than primarily focused on individuals with sexual and re-
productive cancers, as is the case currently [125].
Changes to sexual functioning and sexual activities
were reported by both women and men in the present
study, across people with cancer and partners. This
stands in contrast to the notion that sexual changes are
primarily experienced by men with cancer [79], and are
not an issue of concern for women and partners [126].
The majority of women and men who participated in
the study reported reductions in sexual functioning, sup-
porting previous research [8,9,29,44,127]. As the average
length of time since diagnosis in the present study was
five years, this supports the contention that sexual diffi-
culties can be one of the most enduring effects of cancer
diagnosis and treatment [4].
The inclusion of partners in the current study addressed
the recognition that partners are often neglected in re-
search on sexuality post-cancer [101,103,128]. Women
partners reported reductions across all aspects of sexual
functioning, including sexual frequency, interest, arousal,
and orgasm, whereas men partners reported reductions in
sexual frequency, arousal and orgasm. As the majority of
participants were in a heterosexual relationship, this sug-
gests that when a man has cancer, all aspects of sexual
functioning are diminished for the woman partner. In
contrast, for this sample, when a woman has cancer, her
male partner may maintain sexual interest, but experience
reduced functioning in other aspects of the sexual rela-
tionship. The question of whether this means that sexual
changes are more problematic for men than for women
partners is deserved of further investigation. It has previ-
ously been reported that women do not consider changes
in sexual desire in their male partner with prostate cancer
a major concern, as their primary focus is survival of their
husband [126]. However, qualitative reports in the present
study suggested that sexual changes were problematic for
many women partners, as was also the case for male part-
ners [111,112,129]. This suggests that the sexual concerns
of partners, as well as those of people with cancer, should
be part of the agenda of health professionals working in
cancer care [82,83].
Previous research has suggested that changes in sexual
functioning are associated with reduced quality of life
and psychological distress [10,36,47,48,58,61], relation-
ship satisfaction [36], and couple communication [82,83].
This was confirmed in the correlational analysis in thepresent study, where significant associations were found
between sexual functioning and a range of psychological
and relational variables. There were commonalities and dif-
ferences across men and women, and across people with
cancer and partners, in the strength of the associations be-
tween sexual functioning and psycho-social variables. This
is reflected in the multivariate analysis, which examined
the relative importance of each of the predictor variables.
The finding that the physical component of QoL was a
significant unique predictor of sexual functioning for
men and women with cancer, as well as male partners,
suggests that physical wellbeing is an important deter-
minant of sexual wellbeing after cancer. Deterioration
in physical wellbeing may be associated with cancer
treatment in the case of men and women with cancer
[11,12]. The physical consequences of aging may also
be a factor affecting physical QOL and sexual functioning,
suggested by previous reports that sexual frequency
and functioning declines with age for some individuals
[130,131]. However, the majority of participants in the
present study described sexuality as an important aspect
of their life and relationship, supporting previous reports
that many late middle aged and older adults are sexually
interested and active [132,133]. This refutes the widely
held social construction that older adults are not inter-
ested in sex [134], a construction adopted by some health
professionals working in cancer care [124,135], and sug-
gests that information and support for sexual difficulties
experienced after cancer should be offered to patients
and their partners regardless of age.
In addition to physical QoL, for women with cancer,
depression and mental QoL were unique predictors of
sexual function. The association between psychological
distress and sexual functioning is well documented, for
both women and men in the general population [136,137],
with a bi-directional relationship existing between distress
and sexual difficulties, with both potentially sharing a
common etiology [138]. The gender difference in psycho-
logical predictors of sexual functioning found in the
present study may reflect the lower levels of mental QoL
reported by women with cancer in comparison to men.
However, women did not report significantly higher rates
of depression than men, the other unique predictor, and
whilst they did report higher rates of anxiety, reflecting
gender differences in anxiety in the general population
[139], this was not a significant predictor of sexual func-
tioning. It has previously been reported that marital satis-
faction is associated with sexual functioning [140] and
that women are more likely report marital dissatisfaction
than men, which is associated with depression [141]. In the
present study, relationship satisfaction was significantly
correlated with a greater number of sexual functioning
subscales for women than for men, suggesting that rela-
tionship satisfaction may be a factor in gender differences
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cancer. Gender differences in the relationship between
psychological distress, QoL, sexual functioning and rela-
tionship satisfaction in the context of cancer are deserved
of further examination.
Previous research has demonstrated an association be-
tween couple communication and adjustment in the
context of cancer [86,87,91,142]. Couples who are mutu-
ally responsive, attend to each other’s needs, and talk
openly about their stress, are more able to engage in ef-
fective coping [87], which allows them to find benefits in
the cancer experience, such as personal growth and rela-
tionship closeness [88,89]. This pattern of mutual com-
munication has also been found to be associated with
lower levels of distress for patients and partners, and
higher levels of marital satisfaction [86,143,144]. In the
present study, sexual communication was a significant
predictor of sexual functioning for women with cancer,
and for men and women partners, with higher levels of
communication associated with higher levels of func-
tioning. This supports the findings of a previous study
conducted with men who had prostate cancer and their
partners [39], and suggests that talking about sexual
changes and concerns can play a major part in address-
ing difficulties. In this vein, in previous qualitative re-
search conducted with partners of a person with cancer,
sexual communication was identified as a key factor in
sexual re-negotiation, allowing couples to discuss alter-
native forms of sexual intimacy in the face of physical
changes experienced after cancer [82,107]. The import-
ance of sexual communication in overcoming sexual
difficulties and developing new sexual practices was
also identified in accounts of men and women with
cancer, and partners, in the qualitative component of
the present study [113]. These findings reinforce the
importance of recognizing the inter-subjective nature
of sexual difficulties experienced after cancer, and the
importance of researchers and clinicians adopting a
relational approach [88,145,146], including the devel-
opment of couple-based information and support for
sexual difficulties [147].
In the present study, sexual communication was not
a significant predictor of sexual functioning for men
with cancer in the multivariate analysis, even though
significant associations were found in the correlation
analysis between sexual communication, sexual desire
and pleasure. In the general population, there is evi-
dence that women are more likely than men to dis-
cuss sexual health concerns [148], and that absence of
relationship communication on the part of male partners
causes greater distress for women [149]. It has also been
suggested that women’s wellbeing is more strongly asso-
ciated with relational factors than men’s [150,151]. How-
ever, sexual communication was a predictor of sexualfunctioning for male partners in the present study, sug-
gesting that there is an interaction between gender, the
role of patient/partner, sexual functioning and sexual
communication. The nature and implications of this
interaction is deserved of further investigation.
Relational factors are also implicated in the finding
that the ‘care as self-sacrifice’ subscale of self-silencing
was a unique predictor of sexual functioning in men
with cancer, with lower care as self-sacrifice associated
with higher levels of functioning. In contrast to previous
research examining self-silencing and psychological dis-
tress in cancer carers [98], there was no difference be-
tween men and women partners on levels of self-silencing
in the present study. However, men with cancer reported
significantly higher levels of ‘care as self-sacrifice’ and
‘silencing the self ’ than women with cancer, in line with
previous reports [96,97,152]. The ‘care as self-sacrifice’
subscale, the unique predictor of sexual functioning in the
multivariate analysis, assesses the propensity to put the
needs of others before the self. This suggests that men
who put their partner’s needs first report lower sexual
functioning. Reports from the qualitative aspect of the
present study [114], as well as previous research on women
with cancer [153] and women partners [82], suggests that
some women are engaging in coital sex in order to please
their partner, rather than to fulfill their own needs, even
when coital sex results in pain or discomfort. Men who are
attuned to the woman’s absence of desire or response may
be less likely to initiate sex, and therefore to report lowered
sexual functioning. However, relational closeness may be
maintained through non-coital practices, as evidenced in
the qualitative findings resulting from the present study
[113], suggesting that lowered sexual functioning as mea-
sured by a standardized scale may not be a wholly negative
experience. This suggests that researchers and clinicians
need to be aware of the meaning of sexual functioning for
men and women affected by cancer, and the way in which
this meaning is negotiated in the context of relationships.
Conclusions
The strengths in the present study were the inclusion in
the participant sample of sexual and non-sexual cancers,
men and women, and people with cancer and partners,
across a range of relationship contexts. The utilization
of a range of standardized measures to evaluate sexual
functioning, psychological distress, and relationship sat-
isfaction and communication is also a strength. A limita-
tion was the cross sectional nature of the study, which
did not facilitate examination of changes over time, and
the self-selected nature of the sample, potentially exclud-
ing individuals for whom sexual changes after cancer
were not evident, or were not a concern. A further limi-
tation was the greater proportion of women with breast
cancer in the sample, compared to other cancer types.
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to take part in the research on the part of women with
breast cancer, which may reflect the greater willingness
of women to talk about sexual difficulties combined with
the impact of breast cancer on women’s sexuality [8,15].
However, we also received a good response from individ-
uals and their partners affected by other types of cancer,
including those with prostate, hematological, gastro-
intestinal, neurological, skin, respiratory, and head and
neck cancers, substantiating our conclusion that sexual
changes are experienced by individuals across a range of
cancer types, and that relationship context is an important
predictor of sexual functioning. This suggests that clinicians
and researchers need to acknowledge the psycho-social
context when dealing with sexual changes experienced
after cancer, alongside physical wellbeing, across the whole
spectrum of cancer care.
Changes in sexual activities and sexual functioning
may be one of the most enduring negative effects of can-
cer treatments [5], but distress associated with such
changes can be alleviated, and strategies of sexual re-
negotiation developed [113], through the provision of in-
formation and professional support. However, there is
evidence that discussion of the nature and causes of sex-
ual changes after cancer, as well provision of information
about effective coping strategies, is often absent in clin-
ical consultations [124,135], in particular for women and
for individuals with a non-sexual cancer [135]. As a re-
sult, sexual concerns remain unaddressed [154]. Equally,
whilst a range of one-to-one and couple interventions
have been developed to address sexual difficulties after
cancer [125,155-158], these are primarily focused on the
functioning of the body for individuals with breast, pros-
tate or gynaecological cancer. The findings of the present
study suggest that there needs to be an expansion of such
support into non-sexual cancers. Details of specific strat-
egies that can be adopted in raising sexual issues in a clin-
ical context are now widely available [159-162]; these need
to be utilised as part of normal clinical practice, with both
patients and their partners, across all types of cancer. One
example is the PLISSIT model of providing permission,
limited information, specific suggestions, and intensive
therapy [163]. This model facilitates various levels of inter-
vention, as deemed appropriate for the patient and their
partner: at the most basic level legitimating the discussion
of sex and intimacy within couple relationships and with
health professionals (“permission”); providing “limited in-
formation” through discussion or written information;
“specific suggestions” about changes to sexuality follow-
ing cancer; followed by referral for “intensive therapy” if
needed. At the same time, information and checklists
provided to people with cancer can facilitate their raising
the subject of sexuality with clinicians, which can alleviate
concerns that such discussion is unwanted e.g. [164,165].Competing interests
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